로딩 중…
지수 로딩 중…
Jade Biosciences, Inc.
JBIO· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$16.82-0.30%
2026-06-18
Price Chart
Jade Biosciences, Inc.+78.75%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $830M |
| Revenue | $0.00 |
| Net Income | $-130M |
| Total Assets | $319M |
| Net Assets | $296M |
| Value | |
| P/B | 2.80x |
| FCF Yield | -14.04% |
| Profitability | |
| ROE | -43.72% |
| ROA | -40.57% |
| Financial Health | |
| Debt Ratio | 7.75% |
| Total Debt | $679000.00 |
| FCF | $-117M |
| Cash | $55M |
| Current Ratio | 14.29x |
| Performance | |
| 1Y Return | 78.75% |
| 1M Return | -23.13% |
| From 52W High | -39.93% |
| 1Y MDD | -93.03% |
| Trading | |
| Volume | 3,278,430 shares |
| Trading Value | $56M |
| Per Share | |
| EPS | $-1.80 |
| BPS | $4.70 |